30 October 2018, 14:30-15:30, room STRAUSS 2
The medical technology industry and the nanomedicine field are important economic and social players in Europe. The session will provide insights and examples about how to overcome current challenges, demonstrating medical devices in relevant industrial environments and facilitating the development of new and safe medical technologies. A specific interest will be on the impact of the new EU regulatory frame for medical devices. Attention will also be paid to aspects related to how Test Beds should make design, development, testing, safety assessment and upscaling of new/existing medical device services available to industry in compliance with EU regulatory frameworks, as well as how technologies can help to increase the quality and speed of medical treatments without increasing costs for society.
Please find below the speakers (in alphabetical order), who will contribute to this session:
Moderator: Klaus-Michael Weltring, Nanobioanalytic Muenster, ETP Nanomedicine
Rapporteur: Wim Cuypers